Navigation Links
Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Date:1/17/2008

LA JOLLA, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) announced today that the first phase of a formal "Proof of Concept Trial" for the biopharmaceutical SF-1019 has been successfully completed in Europe for treatment of Diabetic Ulcers.

The Board of Immunosyn was advised as to the success of this important phase of the "Proof of Concept Trial" by Argyll Biotechnologies, LLC its strategic partner and largest shareholder. Argyll Biotechnologies is the developer and licensor of SF-1019, for which Immunosyn has been granted the world-wide rights to market, sell and distribute under an exclusive license agreement.

The primary purpose of the "Proof of Concept Trial" is to further evaluate the safety and efficacy of SF-1019 in the treatment of Diabetic Ulceration and its effect on Diabetic Polyneuropathy in Type 1 Diabetes Mellitus by both subcutaneous injection and by topical application.

Regarding the "Proof of Concept Trial," Professor Angus Dalgleish, MBBS, BSc, MD, FRCP, RACP, FRCPath, FMedSci, Chief Scientist and Consultant Medical Officer for Argyll Biotechnologies, LLC stated that, "This first very important phase in the development of SF-1019, which was undertaken at a European venue, has indicated that SF-1019 promotes wound healing and almost certainly induces growth factors." "When systemically delivered, SF-1019 has shown the rapid resolution of long standing chronic lesions which is very impressive. And the topical application of SF-1019, while showing promise, in that a 5mm deep wound became closed, needs, as expected, unlike the subcutaneous method, more short-term development in order to improve the delivery methodology," he added.

Clinical Director for Argyll Biotechnologies, David Maizels, MD, MSc, MRCS, LRCP, has also advised that, "Because of the positive results, which both the independent clinical team and I have observed during the first phase of the "Proof of Concept
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Immunosyn Corporation Names Stephen Ferrone as CEO
2. Immunosyn Corporation to Begin Trading
3. Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute ... one of the most complex and difficult-to-treat forms ... , Locally advanced pancreatic cancer has the lowest ... cumulative five-year survival rate of only 4 percent ... an option for patients because tumors often involve ...
(Date:7/22/2014)... 2014 The “Human Insulin Market ... Acting, Premixed), Modern Human Insulin (Rapid Acting, Long ... Novomix, Tresiba, Others) - Forecast to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:7/22/2014)... Canadian, Oklahoma (PRWEB) July 22, 2014 ... rehab center, is located in the naturally tranquil and ... Eufaula. , Its location is ideal for both a ... host a traditional Independence Day display of fireworks. ... watch from the beach, while swimming in the lake, ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Atreo Services ... system service and support programs and accessories in booth ... Annual Conference & Technical Exhibition in Chicago, Ill., Aug. ... 6-inch pneumatic tube system carriers as well as its ... common brand-name hospital tube systems. In addition, representatives ...
(Date:7/22/2014)... July 22, 2014 Bramal LED announced that ... with Ed Begley Jr, airing later this year via Discovery ... viewers will learn about Bramal LED’s T-10 lamps, which provide ... consumption by up to 70 percent. Bramal LED’s T-10 lamps ... matter of seconds or on direct AC voltage, with no ...
Breaking Medicine News(10 mins):Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Narconon Arrowhead Holds Annual Firework Event 2Health News:Narconon Arrowhead Holds Annual Firework Event 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Bramal LED to be featured in Upcoming Episode of Innovations with Ed Begley, Jr. 2
... young patients to unnecessary radiation when they order 3-D ... 2-D imaging, suggests a paper published by University of ... the orthodontic community over if and when to use ... treatment planning, said Dr. Sunil Kapila, lead author of ...
... of Massachusetts Medical School (UMMS) and Lundbeck Inc. today ... a targeted therapy to slow or halt the progression ... there is no way to stop or reverse the ... by a triad of progressive motor, cognitive and emotional ...
... 27, 2011) A team of researchers led by ... Saban Research Institute of Children,s Hospital Los Angeles, determined that ... bone mineral density, or bone strength. Length of puberty ... mineral density leads to osteoporosis, resulting in bones becoming increasingly ...
... , FRIDAY, Jan. 28 (HealthDay News) -- ... been known to have difficulty showing empathy, and new ... the same emotional deficiency. The finding suggests that ... to treat frontal brain injury patients, said the researchers ...
... ischemic attack (TIA), sometimes known as a mini-stroke. New ... the American Heart Association shows these attacks may not be ... the brain. The stroke research team, led by ... Research Centre at Vancouver Coastal Health and the University of ...
... By Maureen Salamon HealthDay Reporter , THURSDAY, ... a new restaurant opening in his small Louisiana town, where ... But Burley, an assistant professor of sociology at Southeastern ... heaping helpings of flat-screened TVs -- one in every booth ...
Cached Medicine News:Health News:Powerful 3-D X-rays for kids in braces should be the exception, not the rule 2Health News:UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease 2Health News:UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease 3Health News:Researchers discover age of onset of puberty predicts adult osteoporosis risk 2Health News:Mini-strokes leave 'hidden' brain damage: Vancouver Coastal Health and UBC Research 2Health News:TV: A Sneaky Part of the Food Pyramid 2Health News:TV: A Sneaky Part of the Food Pyramid 3
(Date:7/22/2014)... , July 22, 2014  Based on its ... market, Frost & Sullivan recognizes Siemens Healthcare with ... Siemens Healthcare,s FREEZEit solution, which employs Siemens, MAGNETOM ... robust and motion-insensitive imaging. The solution,s sophistication and ... of body MRI imaging in the U.S. market. ...
(Date:7/22/2014)... MANCHESTER, England , July 22, 2014 ... AEX:PHIA) announced today that The Christie NHS Foundation Trust ... center, will join a consortium whose mission is to ... imaging (MRI) guided radiation therapy system. Such a system ... real-time visualization of cancer targets. "The ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... HARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced,that, ... on the NYSE Amex,Market under the ticker symbol "CBP". , ... On this occasion, ...
... , SOMERVILLE, N.J. , July 7 ... surgical care, announced today the introduction of ETHICON™ ... designed to achieve adjunctive hemostasis (stoppage of bleeding) ... leakage. The US Food and Drug Administration (FDA) ...
Cached Medicine Technology:Renhuang Begins Trading on NYSE Amex 2Renhuang Begins Trading on NYSE Amex 3Renhuang Begins Trading on NYSE Amex 4Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 2Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: